HOLDEN LOWELL THOMAS (CFO) sold 0.1% of their position (5K shares) of NASCENT BIOTECH INC. on the open market
Open‑market sale worth $1.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/25/2022ACC: 0001477932-22-005350
DirectorOfficer· CFO
-5K
Net shares
Net seller
$1.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$0.26
Trade value
$1.30K
% of position
0.1%
—
8.12M→8.11M
Total
Net shares
−5K
Net value
-$1.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | S · Sale | −5K | $0.26 | $1.30K | 0.1% | 8.12M | 8.11M |
| Total | −5K | -$1.30K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.02M
Total
2.02M indirect2.02M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.02M | Indirect |
| Total | 2.02M | 2.02M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported